Nosebleed in Commit - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Nosebleed, when it was recovered, drug effectiveness, race, and more among people who take Commit (nicotine polacrilex). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Commit?

Commit has active ingredients of nicotine polacrilex. eHealthMe is studying from 4,842 Commit users. Check the latest studies of Commit.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,082 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jun, 23, 2026

1 person who has Nosebleed while taking Commit was studied.

Severity of Nosebleed *:

least: 0.0 %
moderate: 0.0 %
severe: 0.0 %
most severe: 100 %

When people recovered from Nosebleed *:

while on drug: 0.0 %
after off the drug: 0.0 %
not yet: 100 %

How effective is Commit:

n/a

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 100 %

Time on Commit *:

Gender of people when taking Commit *:

female: 100 %
male: 0.0 %

Age of people when taking Commit *:

* Approximation only. Some reports may have incomplete information.

Do you take Commit and have Nosebleed?

Check whether Nosebleed is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Nosebleed in Commit

How the study uses the data?

The study is based on nicotine polacrilex (the active ingredients of Commit). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.